Product Images Ondansetron

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Ondansetron NDC 67296-1137 by Redpharm Drug, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 4 mg (30 Tablets Bottle) - ondansetron od fig1

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 4 mg (30 Tablets Bottle) - ondansetron od fig1

This is a bottle of Rising Noc57237-077-30 orally disintegrating tablets containing Ondansetron USP 4 mg. The bottle has 30 tablets and should be stored between 20" to 25°C (68" to 77°F), with excursions permitted to 15° to 30°C (69° to 86°F). The drug comes in a tight, light-resistant container and is distributed by Rising Health, LLC. The dosage instructions and administration can be found in the package insert, and the tablets meet USP Disintegration Test 2. Finally, the containers are made in India and printed with a P1420597 code. Note: This product contains phenylalanine.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 4 mg Blister Carton (3 x 10 Unit-dose) - ondansetron od fig2

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 4 mg Blister Carton (3 x 10 Unit-dose) - ondansetron od fig2

This appears to be a label for a medication called Ondansetron. The medication is in the form of orally disintegrating tablets and is packaged in a bottle of 30 tablets divided into 3 blister cards. The manufacturer is listed as Rising with the NDC number of 57237-077-10. There are also some numbers and text which are not readable, but the majority of the label information is provided.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 8 mg (30 Tablets Bottle) - ondansetron od fig3

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 8 mg (30 Tablets Bottle) - ondansetron od fig3

Rising® Noc57237-078-30 is a medication available in the form of orally disintegrating tablets containing ondansetron USP Ema for the prevention of nausea and vomiting. It is important to note that this medication contains phenylalanine and should only be used as per the doctor's prescription. This medication should be stored at 20°C-25°C (68°F-77°F) with permissible excursions to 15°C-30°C (59°F-86°F). The tablets should be kept in their bottle until use. It meets the USP Disintegration Test 2 and should be dispensed in a tight, light-resistant container as defined by the USP. Other details are not available.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 8 mg Blister Carton (3 x 10 Unit-dose) - ondansetron od fig4

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 8 mg Blister Carton (3 x 10 Unit-dose) - ondansetron od fig4

Chemical Structure - ondansetronod str

Chemical Structure - ondansetronod str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.